These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 17129552

  • 21. Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.
    Lennard L, Cartwright CS, Wade R, Richards SM, Vora A.
    Br J Clin Pharmacol; 2013 Jul; 76(1):125-36. PubMed ID: 23252716
    [Abstract] [Full Text] [Related]

  • 22. Mercaptopurine metabolite results in clinical gastroenterology practice.
    Bloomfeld RS, Onken JE.
    Aliment Pharmacol Ther; 2003 Jan; 17(1):69-73. PubMed ID: 12492734
    [Abstract] [Full Text] [Related]

  • 23. Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.
    Bradford K, Shih DQ.
    World J Gastroenterol; 2011 Oct 07; 17(37):4166-73. PubMed ID: 22072847
    [Abstract] [Full Text] [Related]

  • 24. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
    Sanderson J, Ansari A, Marinaki T, Duley J.
    Ann Clin Biochem; 2004 Jul 07; 41(Pt 4):294-302. PubMed ID: 15298741
    [Abstract] [Full Text] [Related]

  • 25. Quantification of Thiopurine Metabolites in Human Erythrocytes by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Li L, Atkinson N, Crews KR, Molinelli AR.
    Methods Mol Biol; 2024 Jul 07; 2737():443-452. PubMed ID: 38036845
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Clinical pharmacogenomics of thiopurine S-methyltransferase.
    Zhou S.
    Curr Clin Pharmacol; 2006 Jan 07; 1(1):119-28. PubMed ID: 18666383
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.
    Kwan LY, Devlin SM, Mirocha JM, Papadakis KA.
    Dig Liver Dis; 2008 Jun 07; 40(6):425-32. PubMed ID: 18304898
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Possible implication of thiopurine S-methyltransferase in occurrence of infectious episodes during maintenance therapy for childhood lymphoblastic leukemia with mercaptopurine.
    Dervieux T, Médard Y, Verpillat P, Guigonis V, Duval M, Lescoeur B, Suciu S, Vilmer E, Jacqz-Aigrain E.
    Leukemia; 2001 Nov 07; 15(11):1706-12. PubMed ID: 11681411
    [Abstract] [Full Text] [Related]

  • 36. Pharmacogenetics during standardised initiation of thiopurine treatment in inflammatory bowel disease.
    Hindorf U, Lindqvist M, Peterson C, Söderkvist P, Ström M, Hjortswang H, Pousette A, Almer S.
    Gut; 2006 Oct 07; 55(10):1423-31. PubMed ID: 16543290
    [Abstract] [Full Text] [Related]

  • 37. A 6-thioguanine nucleotide threshold level of 400 pmol/8 x 10(8) erythrocytes predicts azathioprine refractoriness in patients with inflammatory bowel disease and normal TPMT activity.
    Roblin X, Peyrin-Biroulet L, Phelip JM, Nancey S, Flourie B.
    Am J Gastroenterol; 2008 Dec 07; 103(12):3115-22. PubMed ID: 19086961
    [Abstract] [Full Text] [Related]

  • 38. Normal thiopurine methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in children with inflammatory bowel disease.
    Kader HA, Wenner WJ, Telega GW, Maller ES, Baldassano RN.
    J Clin Gastroenterol; 2000 Jun 07; 30(4):409-13. PubMed ID: 10875470
    [Abstract] [Full Text] [Related]

  • 39. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M.
    Ther Drug Monit; 2005 Aug 07; 27(4):435-41. PubMed ID: 16044099
    [Abstract] [Full Text] [Related]

  • 40. Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population.
    Hindorf U, Peterson C, Almer S.
    Ther Drug Monit; 2004 Dec 07; 26(6):673-8. PubMed ID: 15570193
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.